A major U.S.-based healthcare technology firm has become one of the first in the sector to integrate significant Bitcoin holdings into its treasury strategy.
The Nasdaq-listed company recently announced a Bitcoin investment totaling around $20 million. This move followed the recent sale of ACT Genomics, strengthening the company's liquidity position significantly. CEO Danny Yeung emphasized that adopting a Bitcoin-centric financial approach bolsters the company's financial stability and marks the beginning of a transformative era in the healthcare sector.
Guiding this pioneering strategy are notable figures such as Andy Cheung, a former top executive at a prominent crypto exchange, and Tracy Hoyos Lopez, known for persuading former U.S. President Donald Trump to support Bitcoin. The firm plans to actively manage its Bitcoin assets using derivatives, yield strategies, and sophisticated institutional-grade techniques.
